Similarly, anti-inflammatory, antioxidant and anti-ischemic properties have been described with GLP-1 receptor agonists.6668 Furthermore, given that adiposity plays a central role in the etiopathogenesis of cardio-reno-metabolic syndrome, GLP-1 receptor agonists would be of particular interest in this clinical context, since they have been shown to be protective at the renal, cardiovascular and metabolic levels, in addition to reducing appetite, weight loss and improved glycemic control.16 Finally, small clinical trials and observational studies are showing modest benefits at the glycemic level and on body weight, both in patients with end-stage renal disease and in renal transplant patients
Vitamin C: The Skins Essential Nutrient What is Vitamin C
Our team of integrative dietitians supports clients where they are, whether that includes using GLP-1 medications or not, with individualized nutrition guidance so body changes do not come at the expense of strength, energy, or health
The broader societal recognition of obesity as a chronic, treatable disease requiring pharmaceutical intervention, combined with expanding global regulatory approvals for Wegovy in new markets, continues to drive prescribing growth and consequently API volume requirements
L-carnitine modulates blood platelet oxidative stress